Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study.
Marre M, Puig JG, Kokot F, Fernandez M, Jermendy G, Opie L, Moyseev V, Scheen A, Ionescu-Tirgoviste C, Saldanha MH, Halabe A, Williams B, Mion Júnior D, Ruiz M, Hermansen K, Tuomilehto J, Finizola B, Gallois Y, Amouyel P, Ollivier JP, Asmar R. Marre M, et al. J Hypertens. 2004 Aug;22(8):1613-22. doi: 10.1097/01.hjh.0000133733.32125.09. J Hypertens. 2004. PMID: 15257186 Free article. Clinical Trial.
Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study.
Hadjadj S, Péan F, Gallois Y, Passa P, Aubert R, Weekers L, Rigalleau V, Bauduceau B, Bekherraz A, Roussel R, Dussol B, Rodier M, Marechaud R, Lefebvre PJ, Marre M; Genesis France-Belgium Study. Hadjadj S, et al. Among authors: marre m. Diabetes Care. 2004 Nov;27(11):2661-8. doi: 10.2337/diacare.27.11.2661. Diabetes Care. 2004. PMID: 15505002 Free article.
Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study.
Azizi M, Ménard J, Peyrard S, Lièvre M, Marre M, Chatellier G. Azizi M, et al. Among authors: marre m. Diabetes Care. 2006 Jun;29(6):1331-6. doi: 10.2337/dc06-0255. Diabetes Care. 2006. PMID: 16732017 Clinical Trial.
Reducing cardiovascular risk in diabetes.
Marre M. Marre M. J Hypertens Suppl. 2007 Jun;25(1):S19-22. doi: 10.1097/01.hjh.0000271505.69949.9d. J Hypertens Suppl. 2007. PMID: 17579314 Review.
Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study.
Vaxillaire M, Veslot J, Dina C, Proença C, Cauchi S, Charpentier G, Tichet J, Fumeron F, Marre M, Meyre D, Balkau B, Froguel P; DESIR Study Group. Vaxillaire M, et al. Among authors: marre m. Diabetes. 2008 Jan;57(1):244-54. doi: 10.2337/db07-0615. Epub 2007 Oct 31. Diabetes. 2008. PMID: 17977958
Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.
Hadjadj S, Fumeron F, Roussel R, Saulnier PJ, Gallois Y, Ankotche A, Travert F, Abi Khalil C, Miot A, Alhenc-Gelas F, Lievre M, Marre M; DIABHYCAR Study Group; DIAB2NEPHROGENE Study Group; SURDIAGENE Study Group. Hadjadj S, et al. Among authors: marre m. Diabetes Care. 2008 Sep;31(9):1847-52. doi: 10.2337/dc07-2079. Epub 2008 Jun 3. Diabetes Care. 2008. PMID: 18523145 Free PMC article.
594 results